K981276

Substantially Equivalent

N-ASSAY L D-BIL

Applicant: Crestat Diagnostics, Inc.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 1998-04-08
Decision date: 1998-05-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seattle, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.